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Abstract
Cystic fibrosis (CF) is a genetic condition affecting the respiratory and gas-
trointestinal systems, with patients experiencing problems maintaining weight,
especially during rapid growth periods such as puberty. The aim of this case
report was to monitor the effect of gastrostomy insertion and implementation
of overnight supplemental feeding upon clinical outcomes, including body
mass index (BMI), lung function (FEV1), and exercise-related variables (maxi-
mal oxygen uptake [VO2max] and ventilatory efficiency [VE/VO2]) in an 11-
year-old female with CF. Combined incremental and supramaximal exercise
testing to exhaustion was performed at four time points: 3 months prior to
the procedure (T1), 2 days prior to (T2), 4 months (T3), and 1 year following
the procedure (T4). Improvements following gastrostomy insertion were
observed at the 1 year follow-up with regards to BMI (+20%); whereas abso-
lute VO2max remained stable and lung function fluctuated throughout the per-
iod of observation. Declines in function with regards to body weight relative
VO2max (16.3%) and oxygen uptake efficiency (+7.5%) were observed during
this period. This case report is the first to consider exercise-related clinical
outcomes in assessing the effect of implementing gastrostomy feeding in CF.
The varied direction and magnitude of the associations between variables
shows that further investigations are required.
Introduction
Cystic fibrosis (CF) is a genetically inherited, life-shortening
disease characterized by respiratory and digestive problems
which manifests in a decreased exercise capacity (Saynor
et al. 2014) and malnutrition (Panagopoulou et al. 2014).
Increased mortality risk is reported when patients exhibit
decreased lung function and poor nutritional status (Liou
et al. 2001). However, exercise-related predictors of mortal-
ity, including maximal oxygen uptake (VO2max) (Pianosi
et al. 2005a) and peak ventilatory equivalent ratio for oxy-
gen (a measure of ventilatory efficiency; VE/VO2) (Hulze-
bos et al. 2014), are also reported in this patient group.
Patients with CF are encouraged to increase their exer-
cise levels (Swisher et al. 2015) and daily caloric intake
(Stallings et al. 2008) to improve clinical outcomes, in
line with clinical practice guidelines (Cystic Fibrosis Trust,
2011). However, nutritional targets are not always met
despite a high level of calorie intake relative to non-CF
controls (Woestenenk et al. 2014). When patients fail to
gain weight as predicted and conservative dietary inter-
ventions fail, invasive support through the insertion of a
percutaneous endoscopic gastrostomy (PEG) may be
required. This procedure has been shown to improve
nutritional status (Williams et al. 1999) and stabilize lung
function (Bradley et al. 2012).
Exercise testing is a valuable tool for evaluating inter-
ventions and profiling the clinical status of patients with
CF (Cystic Fibrosis Trust, 2011), but has yet to be utilized
to assess the effectiveness of this procedure. Therefore,
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this case report is the first to describe exercise-related
changes alongside nutritional status and lung function
following a PEG implant, and supplemental feeding, in a
pediatric patient with CF, over a 15-month period.
Patient Information
The subject of this case report, an 11-year-old female, pre-
sented at birth with meconium ileus requiring surgery and
was subsequently confirmed to have CF (sweat chloride
>60 mmol L1 and homozygous for the DF508 mutation).
Her clinical course through childhood was complicated
by Pseudomonal and Staphylococcal chest infections as
well as relapsing Allergic Broncho-Pulmonary Aspergillosis,
treated with recurrent courses of antibiotics, inhaled
mucoactives (DNase and hypertonic saline), corticos-
teroids, antifungals, and chest physiotherapy (autogenic
drainage and oscillating PEP). She developed impaired glu-
cose tolerance at age 9, then CF-related diabetes requiring
insulin treatment at 10 years of age (as shown in Fig. 1).
During the 15-month period reported in this study, the
patient was unstable (as shown by FEV1 in Fig. 2), and
underwent 22 days of intravenous antibiotic treatment.
Timeline
Changes in clinically important measures of exercise perfor-
mance over a 15-month period were assessed for this report,
with anthropometric and lung function data provided for
the 3 years prior to the procedure and 1 year following.
Exercise testing was conducted at scheduled clinical
appointments, corresponding to four time points: 3 months
preprocedure (T1); 2 days preprocedure (T2); 4 months
postprocedure (T3), and 1 year postprocedure (T4).
A fall in body mass index (BMI) from the 64th to 5th
percentile in 10 months (Fig. 1) prompted the need to
investigate weight gain methods, after conservative dietary
changes (visiting the patient’s school, meetings with par-
ents, and introduction of twice daily Enshake drinks)
failed. Her growth failed to respond to these noninvasive
nutritional supplements, leading to consideration of over-
night supplemental feeding via a PEG.
Diagnostic Assessment
Anthropometric measures
Height was measured to 0.1 cm (Holtain wall-mounted
stadiometer, Crymych, Wales) and body weight to 0.1 kg
(Seca electronic column scale, Birmingham, UK), with
BMI compared to normative percentiles (de Onis et al.
2007).
Lung function
Lung function was assessed using a hand-held spirometer
(MicroPlus, Micro Medical Ltd, Rochester, UK), with
maximal (best of three) values of forced expiratory vol-
ume in 1 sec (FEV1), forced vital capacity (FVC), and
FEV1/FVC ratio being recorded and compared to norma-
tive values (Quanjer et al. 2012).
Exercise parameters
The patient exercised on an electronically braked cycle
ergometer (Lode Excalibur Sport; Lode, Groningen, The
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Figure 1. Changes in body mass index as measured by percentile
in the 3-year period preceding the procedure and 1 year following.
Dashed line at 10.9 years indicates diagnosis of CFRD. Dotted lines
at 11.8, 12.1, 12.4, and 13.1 years indicate T1, T2, T3, and T4,
respectively. Percutaneous endoscopic gastrostomy inserted 2 days
after T2.
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Figure 2. Changes in predicted FEV1 (○) (r = 0.64) and absolute
VO2max (●) (r = 0.40) over the 15-month observation window of
this case report. Four vertical lines indicate T1–T4. Percutaneous
endoscopic gastrostomy inserted 2 days after T2.
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Netherlands), completing a validated (Saynor et al.
2013a) combined ramp-incremental and supramaximal
test to exhaustion to determine VO2max and gas exchange
threshold (Saynor et al. 2014). Measures of VO2max were
normalized to a percentage of predicted maximum (Bon-
gers et al. 2014). The same work rate (15 Wmin1),
warm-up, and recovery timings were used across all tests.
Pulmonary gas exchange was assessed with a calibrated
metabolic cart (Cortex Metalyzer 3B; Cortex Medical,
Leipzig, Germany). Blood oxygen saturation (SpO2) was
measured throughout the test (Nellcor N-20; Medtronic,
Minneapolis, MN) and subjective ratings of perceived
effort and dyspnea were assessed on a 1–10 scale.
Therapeutic Intervention
A PEG tube was inserted under general anesthetic into
the stomach, as described previously (Russell et al. 1984).
Overnight supplemental feeding with 500 mL of Fre-
subin HP Energy (630 kJ/150 kcal) was subsequently
introduced. Composition of the feed (per 100 mL) was as
follows: 7.5 g protein (20% total energy); 17 g carbohy-
drate (45%); and 5.8 g fat (35%). This volume avoided
interference with morning appetite and minimized vomit-
ing risk with physiotherapy.
Follow-Up and Outcomes
Anthropometric outcomes
Anthropometric and pulmonary outcomes are shown in
Table 1. From T1 to T2, increases in height (+1.7 cm),
but a fall in body weight (0.6 kg), resulted in a decrease
in BMI by 0.63 kgm2 (8.6 percentile points). Follow-
ing the PEG procedure (T3), increases in height
(+1.5 cm) and body weight (+3.5 kg), resulted in a gain
of 11.7 BMI percentile points (+1.26 kgm2). At the
1-year (T4) follow-up, height had increased by 3.2 cm
relative to T2, as had body weight (+9.2 kg) and BMI
(+3.02 kgm2), resulting in an increase to the 38th per-
centile for BMI.
Pulmonary outcomes
Changes in lung function (Fig. 2) showed large variation
across the 15-month observation period, although an
overall trend for a decline in function was evident
(r = 0.64). There was an increase in FEV1 from T1
(69.9%) in the lead up to the procedure (T2; 77.1%),
before declining at the subsequent observations, T3
(71.5%) and T4 (59.9%).
Exercise outcomes
Exercise-related measures are listed in Table 2. Time to
exhaustion increased by 49% across all trials (T1–T4),
with an 18% increase observed at the 1-year follow-up
(T2–T4). Absolute VO2max fluctuated over the 15-month
period, decreasing from T1 (1.15 Lmin1) to T2
(1.09 Lmin1), before increasing at T3 (1.18 Lmin1)
and T4 (1.15 Lmin1). When VO2 was expressed relative
to body mass a decrease was observed over the 1-year
follow-up period (16.3% from T2 to T4), a change
associated with the observed weight gain. When normal-
ized for body weight VO2max decreased as a percentage of
predicted from 79.3% (T2) to 66.0% (T4).
Table 1. Changes in anthropometric and lung function measures over the 15-month observation period.
Variable T1 (3M-Pre) T2 (2D-Pre) T3 (4M-Post)
% Change from
T2 to T3 T4 (1Y-Post)
% Change from
T2 to T4
Date 11 June 2014 19 September 2014 19 January 2015 21 September 2015
Age (years) 11.83 12.10 12.44 2.8 13.11 8.4
Height (cm) 146.6 148.3 149.8 1.0 153.0 3.2
Height (percentile) 29.7 30.2 28.6 5.3 29.0 4.0
Weight (kg) 33.9 33.3 36.8 10.5 42.5 27.6
BMI (kgm2) 15.77 15.14 16.40 8.3 18.16 20.0
BMI (percentile) 14.9 6.3 18.0 185.7 38.1 504.8
FVC (L) 1.67 2.06 2.17 5.3 2.23 8.3
FVC (% predicted) 64.3 76.5 78.3 2.4 75.2 1.7
FEV1 (L) 1.61 1.84 1.76 4.4 1.58 14.1
FEV1 (% predicted) 69.9 77.1 71.5 7.3 59.9 22.3
FEV1/FVC (%) 96.41 89.32 81.11 9.2 70.85 20.7
Time points: 3M-Pre (3 months prior to the procedure); 2D-Pre (2 days prior to the procedure); 4M-Post (4 months following the procedure);
1Y-Post (1 year following the procedure). BMI, body mass index; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 sec.
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Changes were observed in relation to VE/VO2, with a
large increase seen between T1 (34.83) and T2 (51.17).
Further, but smaller, increases were then observed at
T3 (53.14, +3.8%) and T4 (55.00, +7.5%), relative to T2.
VE/VCO2 decreased over the 1-year follow-up (T2 = 44.62,
T4 = 42.53; 4.7%), although the magnitude of change
was not as large as that of VE/VO2. Ventilation (VE)
increased from T2 (55.78 Lmin1) to T4 (63.80 Lmin1;
+14.4%).
Discussion
This case report shows the inclusion of exercise-related
factors among short-term fluctuations in clinical mea-
sures, following the insertion of a gastrostomy and imple-
mentation of overnight feeding in a young CF patient.
For this patient to have been considered a ‘normal’
BMI (i.e., 50th percentile), she was required to weigh
39.75 kg at T2. At T4, this requirement was 44.25 kg. The
difference in required and achieved weight at T4
(1.75 kg) relative to T2 (6.45 kg) has justified the require-
ment of the PEG and supplemental feeding. Such gains
are in accordance with prior gastrostomy feeding studies,
which have shown similar increases in body weight (Levy
et al. 1985) and BMI (Truby et al. 2009).
Although lung function has not been shown to increase
following a gastrostomy, studies have shown stabilizing of
function (Williams et al. 1999; Bradley et al. 2012). How-
ever, these studies only present lung function data at dis-
tant time points following such interventions (e.g.,
1 year) and do not provide serial measurements, which
may bias assessment of intervention efficacy, dependent
on the patients function at the time of clinical review.
This case reports all clinical visits (averaging every
41 days; range 7–62 days) over the 15-months follow-up
period and show large fluctuation and a trend for decline
in lung function.
As shown in Figure 2, absolute VO2max remained stable
over the 15 months, despite the fluctuating FEV1, high-
lighting the independence between the two outcomes. As
exercise-related factors can be predictors of mortality
(Pianosi et al. 2005a) and indicators of disease severity
(Thin et al. 2002) when they are very low, it is therefore
important to incorporate such factors in assessing pro-
gression of disease alongside FEV1 and BMI.
Changes in absolute VO2max were minimal and fall
within the typical error associated with the CPET over the
medium term (4–6 weeks; Saynor et al. 2013b) and as
such, a minimal change in predicted absolute VO2max at
the 1-year follow-up (+0.07 Lmin1; 59.0–57.6%; Table 2)
was observed. However, as VO2max is highly dependent on
body size, changes are routinely expressed relative to body
weight, thus resulting in a decrease in body weight relative
VO2max, from T2 to T4 (5.3 mLkg1min1; 79.3–66.0%
Table 2. Changes in exercise-related parameters over the 15-month observation period.
Variable T1 (3M-Pre) T2 (2D-Pre) T3 (4M-Post)
% Change from
T2 to T3 T4 (1Y-Post)
% Change from
T2 to T4
Peak power (W) 84 98 101 3.1 115 17.4
Exercise duration (min) 4 min 43 sec 5 min 58 sec 6 min 17 sec 5 7 min 3 sec 18
VO2max (Lmin1) 1.15 1.09 1.18 8.3 1.16 6.4
VO2max (mLkg1min1) 33.8 32.6 32.2 1.2 27.3 16.3
VO2max (Lmin1; % predicted) 63.8 59.0 62.0 5.1 57.6 2.4
VO2max (mLkg1min1; % predicted) 82.4 79.3 78.1 1.5 66.0 16.8
VCO2 (Lmin1) 1.16 1.25 1.43 14.4 1.50 20.0
RER 1.01 1.15 1.21 5.2 1.29 12.2
VE (Lmin1) 40.06 55.78 62.70 12.4 63.80 14.4
VE/VO2 34.83 51.17 53.14 3.8 55.00 7.5
VE/VCO2 34.53 44.62 43.85 1.7 42.53 4.7
HRmax (beatsmin1)* 196 – 175 –
GET (Lmin1) 0.77 0.71 0.73 2.8 0.65 8.5
GET (% VO2max) 67 65 62 4.6 56 13.9
SpO2 96 98 94 4.1 96 2.0
RPE 5 6 6 0 4 33.3
RPD 4 3 4 33.3 4 33.3
VO2max, maximal oxygen uptake; VCO2, maximal carbon dioxide production; RER, respiratory exchange ratio (VCO2/VO2); VE, minute ventila-
tion; VE/VO2, peak ventilatory equivalent ratio for oxygen; VE/VCO2, ventilatory equivalent for carbon dioxide; HRmax, maximal heart rate; GET,
gas exchange threshold; SpO2, arterial oxygen saturation; RPE, rating of perceived effort; RPD, rating of perceived dyspnea.
*HRmax only available for two tests due to equipment malfunction.
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predicted; Table 2). This change is greater than previously
observed annualized declines (Pianosi et al. 2005b) and the
decline in predicted relative VO2max has a greater magni-
tude of change than the predicted absolute VO2max value.
This decline is of particular relevance given its clinical
implication (i.e., risk of mortality (Pianosi et al. 2005a)
and hospitalization (Perez et al. 2014)). Although it would
normally suggest a deconditioning effect, it could be pro-
posed that the rapid increase in weight (+9.2 kg from T2 to
T4, resulting in an increase of 31.8 BMI percentile points)
is driving this change and deconditioning is not in fact
occurring. However, to appropriately determine and inter-
pret such changes, an accurate assessment of body compo-
sition (e.g., skin folds) is required. However, clinical
constraints prevented such measures in the current report.
Increases in VE without a corresponding increase in
VO2max (Table 2) indicate a reduction in the efficiency of
gaseous exchange. However, given the increase in VCO2
alongside the increase in VE and the stability of VE/VCO2,
it can be suggested that an increase in CO2 release may
be driving the change in ventilation. This is supported by
the rise in RER from T1 to T4, suggesting an increased
‘non-metabolic’ increase in CO2 at maximal exercise per-
haps due to increased anaerobic metabolism, carbohy-
drate metabolism, and/or CO2 storage during exercise.
The increase in peak power (exercise performance) indi-
cates an increase in muscle power, but as no increase in
absolute VO2max was observed, this suggests that oxidative
capacity of the muscle was not enhanced and a greater
contribution likely originated from anaerobic metabolism.
Conclusion
This case report has provided novel data combining clini-
cal and exercise measures in a young patient with CF fol-
lowing the implementation of gastrostomy feeding. Of the
key measures described, BMI increased, whereas relative
VO2max showed a decline due to body weight changes,
amid a fluctuating FEV1. Furthermore, absolute VO2max
remained stable against a decreased function of VE/VO2.
The direct impact of the feeding protocol upon exercise
capacity cannot be directly obtained due to the patients’
clinical instability and lack of a control patient. This case
report does highlight the utility of exercise and body
composition testing in assessing the outcome profile of
individual patients following interventions, warranting its
further use in the assessment and treatment of CF.
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